Finerenone plus empagliflozin combination therapy reduces systolic blood pressure in patients with T2D and chronic kidney disease.
Should pharmacologic treatment of type 2 diabetes start with combination therapy or metformin monotherapy, adding other agents over time? This question was debated at the recent American Diabetes ...
Chemotherapy has been the most effective treatment to date for young and fit patients with chronic lymphocytic leukemia (CLL). The disease is the most common form of leukemia in the Western world, ...
Adding venetoclax to hypomethylating agents increased composite remission but did not improve overall survival in HR-MDS.
Researchers from the University of Alabama at Birmingham have identified a promising new combination therapy for metastatic colorectal cancer that enhances the effectiveness of existing treatment ...
The role of combination therapy is explored for the treatment of COPD. Jeffrey D. Dunn, PharmD, MBA: Let’s discuss guideline-based disease management. I’m going to address this first question to Rey.
Share on Pinterest A new combination therapy for prostate cancer shows promise in clinical trials. Image credit: 1shot Production/Getty Images. A multinational, phase 3 clinical trial – TALAPRO-2 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results